Jounce Therapeutics Garners $47,000,000 Series A Financing Round

  • Feed Type
  • Date
    2/14/2013
  • Company Name
    Jounce Therapeutics
  • Mailing Address
    1030 Massachusetts Avenue Cambridge, MA 02138
  • Company Description
    Jounce Therapeutics is focused on the discovery and development of first-in-class cancer immunotherapies designed to work not by treating a patient’s tumor directly, but instead by harnessing the patient’s immune system to seek out and attack cancerous cells and tumors.
  • Website
    http://www.jouncetx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $47,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Third Rock Ventures

By posting a comment, you agree to our terms and conditions.